Gene · 4048
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Montelukast and Acute Coronary Syndrome: The Endowed Drug. | Pharmaceuticals (Basel) | 2022 | 36145367 | PubTator, text mining | PubMed |
| Leukotriene A4 Hydrolase and Hepatocyte Growth Factor Are Risk Factors of Sudden Cardiac Death Due to First-Ever Myocardial Infarction. | Int J Mol Sci | 2022 | 36142157 | PubTator, text mining | PubMed |
| Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations. | Front Pharmacol | 2022 | 36133811 | PubTator, text mining | PubMed |
| Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease. | Pharm Biol | 2022 | 36124995 | PubTator, text mining | PubMed |
| Current knowledge of the implication of lipid mediators in psoriasis. | Front Immunol | 2022 | 36091036 | PubTator, text mining | PubMed |
| Neutrophil-Epithelial Crosstalk During Intestinal Inflammation. | Cell Mol Gastroenterol Hepatol | 2022 | 36089244 | PubTator, text mining | PubMed |
| Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma. | Cancers (Basel) | 2022 | 36077735 | PubTator, text mining | PubMed |
| Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations. | Int J Mol Sci | 2022 | 36077114 | PubTator, text mining | PubMed |
| The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers. | Front Oncol | 2022 | 36033434 | PubTator, text mining | PubMed |
| Exploring the Impact of ACE Inhibition in Immunity and Disease. | J Renin Angiotensin Aldosterone Syst | 2022 | 36016727 | PubTator, text mining | PubMed |
| Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential. | Pharmaceuticals (Basel) | 2022 | 36015105 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. | Genes (Basel) | 2022 | 36011386 | PubTator, text mining | PubMed |
| The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. | Signal Transduct Target Ther | 2022 | 36008393 | PubTator, text mining | PubMed |
| Uncovering the functions of plasma proteins in ulcerative colitis and identifying biomarkers for BPA-induced severe ulcerative colitis: A plasma proteome analysis. | Ecotoxicol Environ Saf | 2022 | 35999755 | PubTator, text mining | PubMed |
| Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion. | Front Oncol | 2022 | 35978827 | PubTator, text mining | PubMed |
| Formation of eicosanoids and other oxylipins in human macrophages. | Biochem Pharmacol | 2022 | 35973581 | PubTator, text mining | PubMed |
| Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies. | Front Immunol | 2022 | 35958562 | PubTator, text mining | PubMed |
| Current treatment strategies for seasonal allergic rhinitis: where are we heading? | Clin Mol Allergy | 2022 | 35948975 | PubTator, text mining | PubMed |
| Managing SARS-CoV2 Infections Through Resolution of Inflammation by Eicosanoids: A Review. | J Inflamm Res | 2022 | 35937919 | PubTator, text mining | PubMed |
| Expression Profiles and Interaction of MicroRNA and Transcripts in Response to Bovine Leukemia Virus Exposure. | Front Vet Sci | 2022 | 35928115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4048/papers?page=11